Last $0.04 USD
Change Today +0.025 / 166.67%
Volume 600.0
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Israel F. Charo M.D., Ph.D.

Scientist-in-Residence, Bay City Capital LLC
AgeTotal Calculated CompensationThis person is connected to 60 board members in 3 different organizations across 3 different industries.

See Board Relationships


Dr. Israel F. Charo MD, PhD serves as a Scientific Advisor of VIA Pharmaceuticals, Inc. Dr. Charo is a Scientist-in-Residence at Bay City Capital LLC and has been with Bay City since 2009. He is a Senior Investigator/Associate Director at the Gladstone Institute of Cardiovascular Disease at University of California. Dr. Charo studies the role of chemokines in leukocyte trafficking and inflammation. His group cloned the chemokine receptor CCR2, and showed that it is a ...

Read Full Background

Corporate Headquarters*

750 Battery Street
San Francisco, California 94111

United States

Phone: 415-283-2200
Fax: 415-283-2201

Board Members Memberships*

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIAP:US $0.04 USD +0.025


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at